SPY304.32+1.35 0.45%
DIA254.29-0.06 -0.02%
IXIC9,489.87+120.88 1.29%

H.C. Wainwright Maintains Buy on Genmab, Raises Price Target to $29

H.C. Wainwright maintains Genmab (NASDAQ:GMAB) with a Buy and raises the price target from $28 to $29.

Benzinga · 05/07/2020 12:58

H.C. Wainwright maintains Genmab (NASDAQ:GMAB) with a Buy and raises the price target from $28 to $29.